window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-108383172-1'); Skip to content
Novigenix Logo
  • About us
    • Our Story
    • Team
    • Advisors
    • Compliance
    • Career
  • Technology
    • Translational Medicine
    • LITOSeek Platform
  • Solutions
    • Prevention through early detection of cancer
    • Precision medicine
    • Innovative drug target discovery
  • Partnerships
  • News
  • Contact
human-immune-systemSebastien2019-07-16T10:08:02+02:00

Novigenix

Novigenix is an innovative precision medicine company offering liquid biopsy multi-omic solutions powered by the LITOSeek™ AI-RNA analytics platform for better patient outcomes.

Contact us

  • Route de la Corniche 3
    Phenyl Building
    CH-1066 Epalinges
    Switzerland
  • partnerships@novigenix.com

Follow us on LinkedIn

Recent posts

  • Breakthrough study reveals blood transcriptomic alternations for early detection of colorectal cancer
  • Understanding Tumor Immunology: How AI-powered blood RNA analysis could unlock immunotherapy prognoses
  • Prostate cancer breakthrough: Novigenix-led project receives €1.75M grant to improve patient outcomes using liquid biopsy technology

Newsletter

COPYRIGHT 2024 NOVIGENIX SA | ALL RIGHTS RESERVED | PRIVACY POLICY | POWERED BY AGENCE-ACP |
Page load link
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Learn more Ok

Privacy Notice

Go to Top